Amanta Healthcare Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
AMANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amanta Healthcare Limited has submitted a statement to the Exchange regarding any deviations or variations in the use of proceeds raised from a public, rights, or preferential issue, as required under Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations. Reg. 32 filings are mandatory for companies that have raised funds through capital market issuances, and they report whether the money was spent as originally disclosed in the offer document. The headline itself does not specify whether there were any actual deviations or whether this is a nil deviation report, so the specific details of fund usage would need to be checked in the attached document.
For shareholders, this is a routine compliance filing under SEBI rules. If the statement reports no deviations, it is a neutral disclosure confirming funds were used as intended. If it highlights deviations or variations in fund usage, investors should review the details to assess whether the change in purpose or timing of spending could affect the company's growth plans or financial discipline.